A FORECAST shortfall in the UK’s vaccine supply has been put down to a delay in the delivery of five million doses of the Oxford-AstraZeneca jag from India.
The shipment had been expected from the Serum Institute of India, the BBC reported, but has been held up by four weeks.
A leaked letter to health leaders in England warned of a "significant reduction in weekly supply" of the vaccine from March 29, "meaning volumes for first doses will be significantly constrained".
The letter from chief commercial officer Emily Lawson and medical director for primary care, Dr Nikita Kanani, said people "aged 49 years or younger should not be offered vaccination" unless they are in a higher priority group, such as being clinically vulnerable.
It added that the UK's vaccines taskforce predicts the shortfall will last four weeks "as a result of reductions in national inbound vaccines supply".
READ MORE: Concern over weekly increase in Covid cases in Glasgow and the central belt
The Department of Health has said the UK Government is still on track to offer a first dose to all adults by the end of July.
In Scotland, more than two million people have received their first dose, with 44% of the eligible population having had at least one jag.
"Virtually all" over-65s have now had the first dose, as well as 67% of 60 to 64-year-olds, the Scottish Government announced.
A spokesperson for the Serum Institute of India told the BBC: "Five million doses had been delivered a few weeks ago to the UK and we will try to supply more later, based on the current situation and the requirement for the government immunisation programme in India."
AstraZeneca has partnered with the institute, which is the world's largest vaccine manufacturer, for supplies to the Indian government but also to other countries, including low and middle-income ones.
Cabinet minister Robert Jenrick conceded the rollout of vaccines would be slightly slower than expected because of the shortage.
Tory Housing Secretary told BBC Breakfast: "We are experiencing some supply issues so it does mean the vaccine rollout will be slightly slower than we may have hoped but not slower than the target we set ourselves.
"We're going to move forward as quickly as we possibly can but it won't be as fast as we might have hoped for a few weeks, but then we have every reason to believe that supply will increase in the months of May, June and July."
Meanwhile, the European Medicines Agency (EMA) will publish its findings on the AstraZeneca vaccine on Thursday, after more than a dozen European countries suspended rollout of the jab over a small number of cases of blood clotting.
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here